Abstract
Activation by parathyroid hormone (PTH)1 and peripheral distribution2,3 the of PTH2 receptor (PTH2-R) are well described. Highest expression of PTH2-R is found in the brain1, where PTH synthesis is undetectable. We have now purified and sequenced a new polypeptide from bovine hypothalamus (referred to here as tuberoinfundibular peptide of 39 residues; TIP39), a potent and selective agonist at the PTH2-R. The PTH2-R was highly expressed in hypothalamic areas that regulate pituitary hormone secretion and spinal cord regions involved in pain perception.
References
Usdin, T. B., Gruber, C. & Bonner, T. I. J. Biol. Chem. 270, 15455–15458 (1995).
Usdin, T. B. Endocrinology 138, 831–838 (1997).
Behar, V. et al. Endocrinology 137, 2748–2757 (1996).
Gardella, T. J., Luck, M. D., Jensen, G. S., Usdin, T. B. & Jüppner, H. J. Biol. Chem. 271, 19888–19893 (1996).
Hoare, S. R. J., Bonner, T. I. & Usdin, T. B. Endocrinology (in press).
Usdin, T. B. et al. Endocrinology 140, 3363–3371 (1999).
Platika, D., Boulos, M. H., Baizer, L. & Fishman, M. C. Proc. Natl. Acad. Sci. USA 82, 3499–3503 (1985).
Cui, M. & Nicol, G. D. Neuroscience 66, 459–466 (1995).
Hingtgen, C. M., Waite, K. J. & Vasko, M. R. J. Neurosci. 15, 5411–5419 (1995).
Pang, P. K. T., Kaneko, T. & Harvey, S. Am. J. Physiol. 255, R643–R647 (1988).
Fraser, R. A., Kronenberg, H. M., Pang, P. K. T. & Harvey, S. Endocrinology 127, 2517–2522 (1990).
Urban, J. H., Brownfield, M. S., Levine, J. E. & Van de Kar, L. D. Neuroendocrinology 55, 574–582 (1992).
Van de Kar, L. D., Urban, J. H., Brownfield, M. S. & Simmons, W. H. Hypertension 9, 598–606 (1987).
Usdin, T. B., Bonner, T. I., Harta, G. & Mezey, É . Endocrinology 137, 4285–4297 (1996).
Bennett, H. P., Hudson, A. M., Kelly, L., McMartin, C. & Purdon, G. E. Biochem. J. 175, 1139–1141 (1978).
Acknowledgements
Large-scale tissue extraction was performed by Thomas McCloud and Andrew Burnette of the National Cancer Institute Natural Products Support Group and microsequencing by the Harvard University Microchemistry Facility. TIP39 was synthesized by AnaSpec, Inc. F-11 and N18TG2 cells were obtained from H. Gainer. We thank Chris Evans, Lisa Baptiste, Ed Unsworth and Howard Jaffe for advice and assistance and Mike Brownstein and Hal Gainer for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Usdin, T., Hoare, S., Wang, T. et al. TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci 2, 941–943 (1999). https://doi.org/10.1038/14724
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/14724
- Springer Nature America, Inc.
This article is cited by
-
PTH levels, sleep quality, and cognitive function in primary hyperparathyroidism
Endocrine (2023)
-
Cognitive deficits in primary hyperparathyroidism – what we know and what we do not know: A narrative review
Reviews in Endocrine and Metabolic Disorders (2022)
-
Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism
Journal of Endocrinological Investigation (2022)
-
The association between hypoparathyroidism and cognitive impairment: a systematic review
Journal of Endocrinological Investigation (2021)
-
Maternally involved galanin neurons in the preoptic area of the rat
Brain Structure and Function (2017)